ADiTx Therapeutics Inc. [NASDAQ: ADTX] price surged by 5.70 percent to reach at $0.11. The company report on November 19, 2020 that Aditxt Secures CLIA Certification for AditxtScore™ Laboratory Operations in Richmond, VA, and Plans to Launch AditxtScore™ for COVID-19 as a Lab Developed Test (LDT).
Upcoming Vaccines Increase the Need for Ongoing Monitoring of Presence and Durability of Immunity.
via NewMediaWire — Aditx Therapeutics, Inc. (Aditxt) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that its AditxtScore™laboratory operations for immune monitoring has secured CLIA certification, allowing for the launch of AditxtScore™for COVID-19 as a Laboratory Developed Test (LDT).
A sum of 9856178 shares traded at recent session while its average daily volume was at 762.61K shares. ADiTx Therapeutics Inc. shares reached a high of $2.40 and dropped to a low of $1.96 until finishing in the latest session at $2.04.
Guru’s Opinion on ADiTx Therapeutics Inc. [ADTX]:
The Average True Range (ATR) for ADiTx Therapeutics Inc. is set at 0.15
ADTX Stock Performance Analysis:
ADiTx Therapeutics Inc. [ADTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.25.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADTX stock in for the last two-week period is set at 54.30, with the RSI for the last a single of trading hit 57.47, and the three-weeks RSI is set at 47.12 for ADiTx Therapeutics Inc. [ADTX]. The present Moving Average for the last 50 days of trading for this stock 1.98, while it was recorded at 1.96 for the last single week of trading.
Insight into ADiTx Therapeutics Inc. Fundamentals:
Reflecting on the efficiency of the workforce at the company, ADiTx Therapeutics Inc. [ADTX] managed to generate an average of -$2,913,864 per employee.ADiTx Therapeutics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.00 and a Current Ratio set at 0.00.
ADiTx Therapeutics Inc. [ADTX] Insider Position Details
There are presently around $1 million, or 7.60% of ADTX stock, in the hands of institutional investors. The top three institutional holders of ADTX stocks are: SABBY MANAGEMENT, LLC with ownership of 224,971, which is approximately New of the company’s market cap and around 5.90% of the total institutional ownership; WEDBUSH SECURITIES INC, holding 61,832 shares of the stock with an approximate value of $0.13 million in ADTX stocks shares; and POWELL INVESTMENT ADVISORS, LLC, currently with $79000.0 in ADTX stock with ownership of nearly New of the company’s market capitalization.
9 institutional holders increased their position in ADiTx Therapeutics Inc. [NASDAQ:ADTX] by around 358,221 shares. Additionally, 2 investors decreased positions by around 110,461 shares, while 0 investors held positions by with 110,461 shares. The mentioned changes placed institutional holdings at 358,221 shares, according to the latest SEC report filing. ADTX stock had 9 new institutional investments in for a total of 358,221 shares, while 2 institutional investors sold positions of 110,461 shares during the same period.